Brian K. Halak, 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 650,000 shares at $7.50 ($4.9M) on 2009-07-23, disclosed to the SEC on 2009-07-24.
Open-market purchase of $4.9M OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 10,901 | $82K | 1.7% |
| 2 | $7.50 | 639,099 | $4.8M | 98.3% |
| Total | $7.50 avg | 650,000 | $4.9M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |